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events within the glomerulus may provide potential therapeuticOxidized low-density lipoprotein stimulates monocyte adhe-
modalities in monocyte/macrophage-mediated glomerular dis-sion to glomerular endothelial cells.
ease.Background. Abnormalities in lipid and lipoprotein metab-
olism have been implicated in the pathogenesis of glomerulo-
sclerosis. Atherogenic lipoproteins [for example, low-density
lipoprotein (LDL) and oxidized LDL (ox-LDL)] have been
Abnormalities in lipid and lipoprotein metabolism areshown to stimulate glomerular monocyte chemoattractants in-
commonly associated with diverse renal diseases [1, 2].volved in monocyte infiltration. However, the role of LDL
and ox-LDL in the early monocyte adhesion to glomerular Hyperlipidemia and increased plasma atherogenic lipo-
endothelial cells (ECs) and associated intracellular signaling proteins [for example, low-density lipoprotein (LDL)],
mechanisms are not clearly understood. at least in part, are thought to contribute to the highMethods. In this study, we examined the effect of LDL and
incidence of atherosclerotic cardiovascular events andox-LDL on intracellular signaling mechanisms associated with
monocyte adhesion to glomerular ECs and intercellular adhe- mortality noted in patients with renal disease [1–3]. Ad-
sion molecule-1 (ICAM-1) expression. ditionally, studies in experimental animals and in in vitro
Results. Ox-LDL, but not LDL, stimulated EC ICAM-1 ex- tissue culture systems have implicated the critical role
pression and monocyte adhesion. Ox-LDL elevated protein
of hyperlipidemia and atherogenic lipoproteins in thetyrosine kinase (PTK) activity, and the preincubation of ECs
development of glomerular disease. For example, choles-with specific PTK inhibitors blocked ox-LDL–induced ICAM-1
message and monocyte adhesion. Whereas experimental ma- terol feeding to experimental animals or endogenous
neuvers that inhibit either protein kinase C activation (by PKC hyperlipidemia in animals provoked the development of
depletion or with inhibitors) or Gi-protein–mediated pathways glomerular injury, and the use of specific lipid-lowering(pertussis toxin sensitive) had no effect on ox-LDL–induced
drugs prevented the development of glomerulosclerosismonocyte adhesion and ICAM-1 expression. cAMP-elevating
compounds did not induce ICAM-1 or monocyte adhesion. [1, 4]. Furthermore, we and others have recently shown
Conclusions. The data indicate that ox-LDL, by stimulating that the activation of glomerular mesangial cells with
monocyte adhesion to the glomerular endothelium, may regu- LDL and with greater activity oxidatively modified vari-late monocyte infiltration within the glomerulus, supporting
ants of LDL, stimulated the glomerular pathobiologicalan early pathobiological role for atherogenic lipoproteins in
events associated with glomerular injury [5–8]. Recogniz-glomerular injury. The results suggest that the activation of
specific PTK and associated signaling may, at least in part, ing the vascular organization of the glomerulus and that
play a critical role in ox-LDL–mediated endothelial–monocyte the kidney is perfused by a significant portion of the
interaction-related events. The data suggest that the interven-
cardiac output, we hypothesized that the retention oftions aimed at modifying associated intracellular signaling
LDL and its potential oxidative modification by intrinsic
cells (exhibiting higher atherogenic potential) within the
1 Present address: Gastroenterology Research Laboratories, Depart- glomerulus may initiate a cascade of cellular events thatment of Veterans Affairs Medical Center, Long Beach, CA.
are involved in the development of glomerulosclerosis2 Present address: Department of Pharmacology, Yonsei University
College of Medicine, Seoul, Korea. [9, 10].
The enhanced adherence of circulating monocytes toKey words: lipid metabolism, lipoprotein, glomerulosclerosis, intracel-
lular signaling, cell signaling. the glomerular capillary endothelium and subsequent
monocyte infiltration into the mesangium are predomi-
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mechanisms that underlie monocyte infiltration and ac- merular endothelial adhesion molecule expression and
related monocyte adhesion activities is largely unknown.cumulation within the glomerulus are thought to be me-
In this investigation, studies were performed to exam-diated by complex ligand–receptor interactions between
ine the role of native and oxidatively modified LDL onresident glomerular cells and circulating leukocytes.
glomerular EC expression of ICAM-1 and monocyteThese interactions are proposed to be mediated by the
adhesion. Furthermore, we examined the involvementenhanced expression of glomerular endothelial adhesion
of multiple signal transduction pathways including PKC,molecules and by the elaborated expression of monocyte
PTK, and Gi-protein–mediated processes in atherogenicchemoattractant peptides by activated intrinsic glomeru-
lipoprotein-induced ICAM-1 gene expression and mono-lar cells [13, 14]. Intercellular adhesion molecule-1
cyte adhesion to ECs.(ICAM-1), a member of the immunoglobulin supergene
family, is one of the several recently described human
cell adhesion molecules that play a central role in the METHODS
generation of inflammatory or immune responses, in-
Materialscluding interactions between immune and other acces-
Dulbecco’s minimal essential medium (DMEM),sory cells [15, 16]. The interaction of ICAM-1 with its
Ham’s F-12 medium, RPMI 1640, trypsin ethylenedi-specific ligand, lymphocyte function-associated antigen
aminetetraacetic acid (EDTA) solution, fetal bovine se-(LFA-1), has been shown to be critical for a number of
rum (FBS), dibutyryl cAMP, phorbol myristic acetateadhesion events among leukocytes and other cell types
(PMA), and other tissue culture reagents were obtained[17, 18].
from Sigma Chemical Co. (St. Louis MO, USA). ADespite the increased expression of cellular adhesion
cDNA probe for murine ICAM-1 and human glyceralde-molecules and the subsequent accumulation of monocyte/
hyde-3-phosphate dehydrogenase (GAPDH) was pur-macrophage in the mesangium of many experimental and
chased from American Type Culture Collection (ATCC,human glomerular disease, the endogenous modulators
Rockville, MD, USA). Deoxycytidine-59-[a-32p]triphos-that influence the cellular and molecular mechanisms
phate (specific activity 5 3000 Ci/mmol) and sodiumassociated with this inflammatory processes are poorly un-
chromate (specific activity 5 340.6 mCi/mg chromium)derstood. Previous studies have indicated that the mono-
were obtained from Amersham Corporation (Arlingtoncytes adhere more avidly, transmigrate through endothe-
Heights, IL, USA). MSI nylon transfer membranes andlial cell (EC) junctions, and enter the subintimal space
nitrocellulose membranes were obtained from Fisherof the vascular endothelium and glomerular mesangium
Scientific (Tustin, CA, USA). Calphostin C, pertussisin experimental animals that were fed a high-cholesterol
toxin, genistein, and herbimycin A were purchased from
diet [1–3]. Recently, we and others have shown that the
Calbiochem (La Jolla, CA, USA). Murine monoclonal
activation of glomerular mesangial cells with LDL and, ICAM-1 antiserum was obtained from PharMingen (San
with greater activity, oxidized-LDL (ox-LDL), through Diego, CA, USA). All other chemicals used were of
up-regulation of monocyte chemotactic protein-1 (MCP-1) analytical grade.
and monocyte colony-stimulating factor (M-CSF), stimu-
lated monocyte chemotaxis [6–9]. However, the role of Cell culture
atherogenic lipoproteins in early cellular events associ- Murine glomerular ECs were kindly provided by Dr.
ated with monocyte adhesion to glomerular ECs is not Gary Striker (National Institutes of Health, Bethesda,
known. Furthermore, the intracellular signaling path- MD, USA), grown in DMEM 1 Ham’s F-12 (at a 3:1
ways involved in EC adhesion molecule expression and ratio) containing 10% FBS in a humidified incubator for
monocyte adhesion to ECs are not clearly understood. two to three days, and then subcultured. These cells were
In this regard, atherogenic lipoproteins recently have characterized by the original investigators based on the
been shown to modulate various signaling pathways, in- morphological characteristics and surface markers. Con-
cluding protein kinase C (PKC), Gi-proteins, cAMP- fluent cells were subcultured, and cells between 4 and
dependent kinase, and protein tyrosine kinase (PTK) 10 passages were used for the experimental studies. A
[19–26]. Previous studies have shown the involvement murine monocyte/macrophage cell line (J774.A1, ob-
of PTK-mediated pathways in tumor necrosis factor-a tained from ATCC) cultured in RPMI 1640 supple-
(TNF-a)–induced adhesion molecule expression in vas- mented with l-glutamine, penicillin/streptomycin, and
cular endothelial and glomerular mesangial cells [27, 28] 10% FBS was used in adhesion studies.
and cAMP-dependent pathways in minimally modified
Low-density lipoprotein isolation and oxidizedLDL-mediated vascular cell MCP-1 and M-CSF expres-
low-density lipoprotein preparationsion and monocyte adhesion [20]. Whether or not any
of these intracellular signaling events in atherogenic lipo- Blood samples were collected from healthy human
volunteers, serum isolated by centrifugation, and sam-protein-mediated cellular processes are involved in glo-
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ples were pooled for LDL isolation as described earlier Northern analysis. Based on previous studies performed
in this and other laboratories, we have used the optimum[5, 6]. Oxidized-LDL was prepared by incubating LDL
with CuSO4, and oxidative modification measured by concentration and incubation time for various kinase
inducers or inhibitors to determine the involvement ofelectrophoretic mobility and increased thiobarbituric
acid reactive substances [6]. The electrophoretic mobility various intracellular signaling mechanisms in ICAM-1
mRNA expression [28, 30]. The effect of PKC on ECof ox-LDL on agarose gel was fourfold to fivefold higher
than native LDL. The concentrations of thiobarbituric ICAM-1 message was evaluated by incubating cells for
four hours with PMA (50 nm), an activator of PKC. Inacid-reactive substances in ox-LDL samples were 2- to
2.5-fold higher than native LDL. During LDL isolation other experiments, intracellular PKC was depleted by
incubating ECs with 50 nm PMA for 24 to 48 hours. Afterand ox-LDL preparation, appropriate precautions were
taken to avoid endotoxin contamination [6]. The endo- depletion of intracellular PKC, ECs were stimulated by
incubating with either PMA (50 nm) or ox-LDL (50 mg/ml)toxin concentrations in LDL and ox-LDL ranged from
0.1 to 0.2 pg/mg of lipoproteins, as determined by limulus for four hours. Further experiments were performed by
preincubating ECs with calphostin C (100 nm for oneamebocyte lysate assay kit (BioWhittaker Inc., Walk-
ersville, MD, USA). More than 1.5 to 2.0 ng/ml of endo- hr), a specific PKC inhibitor, prior to the stimulation of
cells with either PMA or ox-LDL for four hours. Aftertoxin were required to induce ICAM-1 expression (data
not shown), a concentration well above the levels of incubation, cell monolayers were washed with phos-
phate-buffered saline (PBS) and used for RNA isolation.endotoxin contamination that were detected in the LDL
or ox-LDL preparations (10 to 20 pg of endotoxin/ml of The role of PTK was examined by preincubating ECs
with herbimycin (10 mm for one hr), a specific PTK inhibi-media) that were used for various protocols. A preserva-
tive mixture containing antioxidants and protease inhibi- tor, prior to the stimulation of cells with ox-LDL
(50 mg/ml) for four hours. Cells were washed with PBS,tors was added during LDL isolation and storage to avoid
oxidative modification [5, 6]. and RNA was isolated for Northern blot analysis. An-
other set of studies was designed to examine the role of
Monocyte-endothelial cell adhesion assay G proteins in EC ICAM-1 mRNA expression. Quiescent
ECs were preincubated with pertussis toxin (50 ng/ml)The effect of lipoproteins on monocyte adhesion to
ECs was evaluated by a monolayer collection assay [29]. for two hours and were then stimulated with ox-LDL
(50 mg/ml) for four hours. The cell monolayers wereMonocytes were grown in RPMI 1640 containing 10%
FBS and were labeled with 51Cr as described earlier [28, washed and used for RNA isolation.
29]. ECs grown in DMEM 1 Ham’s F-12 [3:1] 1 10%
Monocyte-endothelial cell adhesion:FBS were incubated with either LDL or ox-LDL (5 to
Role of protein kinases100 mg/ml) and incubated for 24 hours. The media were
replaced with fresh DMEM containing 1% FBS, and 100 The involvement of various protein kinases on mono-
cyte adhesion to ECs was examined by measuring mono-ml of 51Cr-labeled monocytes (0.2 3 106 cells) were added
to the wells containing ECs. After three hours of incuba- cyte–EC adhesion in presence of stimulators or inhibitors
of specific protein kinases. The role of PKC in mono-tion at 378C, cell monolayers were gently washed (3 3
with DMEM 1 1% FBS) to remove nonadherent mono- cyte–EC adhesion was examined by incubating ECs with
PMA (50 nm) for either 4 or 24 hours (to activate orcytes. The adherent monocytes were digested with 0.5 m
NaOH, and an aliquot was used to measure the radioac- deplete PKC, respectively) prior to the addition of radio-
labeled monocytes for adhesion assay. The involvementtivity as an index of monocyte adhesion to ECs. ICAM-
1–mediated monocyte adhesion to ECs in response to of PKC in ox-LDL–stimulated monocyte adhesion to
ECs was examined by incubating PKC-depleted ECslipoprotein was assessed by adding saturating concentra-
tions of murine anti–ICAM-1 (10 mg/ml) to the adhesion with ox-LDL (50 mg/ml) for 24 hours. A monocyte adhe-
sion assay was performed as described earlier here. Addi-assay two hours prior to the addition of monocytes.
tional experiments were performed by preincubating
Endothelial cell intercellular adhesion molecule-1 ECs with calphostin C (100 nm) for one hour and stimu-
mRNA expression lating with ox-LDL (50 mg/ml) for 24 hours prior to
examining monocyte adhesion. The effect of PTK inhibi-Endothelial cells (4 3 106) were grown in DMEM 1
Ham’s F12 containing 10% FBS at 378C for 24 hours to tors on monocyte adhesion was examined by preincubat-
ing ECs with either herbimycin (5 mm) or genistein (12.5attain 75 to 80% confluence. The cells were incubated
in serum-free DMEM 1 Ham’s F12 for 24 hours. Media mg/ml) for two hours, and then incubating with ox-LDL
(50 mg/ml) for 24 hours prior to the addition of radiola-were replaced with fresh serum-free medium containing
LDL or ox-LDL (5 to 100 mg/ml) and were incubated beled monocytes for the adhesion assay. Similarly, ECs
were preincubated with pertussis toxin (50 ng/ml) forfor 4 and 24 hours at 378C. After incubation, the cell
monolayer was washed and used for RNA isolation and two hours and ox-LDL (50 mg/ml) for 24 hours prior to
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the addition of radiolabeled monocytes for the adhesion at low levels in glomerular ECs under normal or unstimu-
lated conditions. Incubation of ECs with ox-LDL (0 toassay. The respective inhibitors were present throughout
the incubation period. 100 mg/ml) dose dependently stimulated the steady-state
mRNA expression of ICAM-1 (Fig. 1). In multiple ex-
Northern blot analysis periments, the maximum effect was seen between 50 and
100 mg/ml of ox-LDL doses, and the effect of ox-LDLTotal RNA was isolated from the cells using the proto-
col described by Chomczynski and Sacci [31]. Thirty mi- at higher doses appeared to be reduced as compared
with ox-LDL doses of 50 or 100 mg/ml (data not shown).crograms of total RNA were loaded into individual wells
of a 1.2% agarose gel containing formaldehyde, and elec- However, at similar doses, LDL had no effect on EC
ICAM-1 mRNA expression (Fig. 1). The densitometrictrophoresis was performed. The RNA from the gel was
transferred onto MSI nylon membranes using a capil- quantitative analysis of ICAM-1 mRNA message showed
the following arbitrary units: control 5 0.67; LDL at 5,lary transblot technique, ultraviolet linked, and hybrid-
ized with [32P]dCTP-labeled cDNA probes for murine 10, 50, 100 mg/ml 5 0.64, 0.68, 0.65, 0.6, respectively; and
ox-LDL at 5, 10, 50, 100 mg/ml 5 0.68, 0.7, 0.82, 1.58,ICAM-1 and GAPDH. Quantitation of mRNA signals
was performed by densitometric scanning of auto- respectively. The induction of ICAM-1 message by
ox-LDL was similar in ECs incubated either for 4 or 24radiographs and was normalized with the respective
GAPDH mRNA signal. hours, and subsequent experiments were performed with
a four-hour incubation (data not shown). Lysophosphati-
In vitro protein tyrosine kinase assay dylcholine (Lysopc; 25 to 100 mm; a major component
of ox-LDL) also increased EC ICAM-1 mRNA expres-Protein tyrosine kinase activity was measured in cellu-
lar membranes by using RR-SRC peptide (12-amino acid sion by approximately 35 to 50% as compared with con-
trols (data not shown). EC surface expression of ICAM-1sequence surrounding tyrosine phosphorylation site in
pp60src; assay kit from Life Technologies, GIBCO BRL was examined by Western blot analysis. Quantitative
analysis of Western blots by densitometry indicated thatProducts, Grand Island, NY, USA) as a substrate at 308C
for 20 minutes in a buffer containing 30 mm HEPES, pH the incubation of ECs with ox-LDL (24-hr incubation),
but not LDL, dose dependently increased ICAM-1 cellu-7.4, 10 mm MgCl2, 1 mm DTT, 25 mg/ml bovine serum
albumin (BSA), 0.15% Nonidet P-40, 0.07 mm sodium lar protein expression, as compared with control (quanti-
tative arbitrary units: control 5 0.09, ox-LDL at 10 andorthovanadate, 0.06 mm adenosine 59-triphosphate (ATP),
and 4 mCi [g-32P]ATP. The reaction was initiated by 50 mg/ml doses 5 0.23 and 0.43, respectively; data are the
mean of two experiments done in duplicate). Ox-LDL,adding cell membrane preparations (21,000 r.p.m. frac-
tion; 10 mg protein) activated by incubation with either at various doses and incubation periods used in this
study, had no effect on EC viability and toxicity, as mea-PBS (control), LDL (10 mg/ml), or ox-LDL (10 mg/ml)
on ice for 15 or 30 minutes. After the incubation, 20 sured by trypan blue exclusion criteria and by measuring
cellular protein levels.ml of 10% ice-cold trichloroacetic acid were added to
precipitate the endogenous cellular proteins, incubated
Effect of LDL and ox-LDL on monocyte adhesion toon ice for 10 minutes, and centrifuged at 14,000 3 g for
endothelial cells10 minutes. A 35 ml aliquot was spotted onto phosphocel-
lulose discs (Whatman p81 phosphocellulose paper), Because the results of Northern and Western analysis
indicated that the activation of ECs with ox-LDL stimu-washed four times with 180 mm phosphoric acid, and
rinsed once with 95% ethanol and air dried, and [32P]ATP lates ICAM-1 mRNA and protein expression, further
studies were performed to examine the ability of ox-LDL–incorporation was measured as an index of PTK activity.
induced ICAM-1 to stimulate monocyte adhesion to ECs.
Statistical analysis Preincubation of ECs with varying concentrations of ox-
LDL (0 to 50 mg/ml) for 24 hours markedly increasedResults are presented as mean values 6 se for three
to four separate experiments. The Student’s t-test was monocyte adhesion to ECs by 1.5- to 3-fold in a dose-
dependent manner (Fig. 2A). At similar doses, LDL didused for statistical analyses.
not stimulate monocyte adhesion to ECs (Fig. 2A). The
specific involvement of ICAM-1 to induce the adhesion
RESULTS
of monocytes to ECs was examined by using a specific
Effect of LDL and ox-LDL on endothelial cell neutralizing antibody for murine ICAM-1. Data from
ICAM-1 protein and steady-state mRNA expression these studies indicated that the preincubation of ECs
with anti–ICAM-1 antibody (10 mg/ml; this dose of anti-Murine glomerular ECs were used as an in vitro model
to examine the comparative effects of native LDL and body was shown to have the maximum effect in compari-
son with various concentrations, 2 to 20 mg/ml) for twoox-LDL on the expression of ICAM-1 and their ability
to induce monocyte adhesion. ICAM-1 could be detected hours significantly inhibited ox-LDL–induced adhesion
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Fig. 1. Effect of low density lipoprotein
(LDL) and oxidized low density lipoprotein
(ox-LDL) on steady-state mRNA expression
of intercellular adhesion molecule-1 (ICAM-1)
by endothelial cells. Quiescent endothelial cells
were incubated with either LDL or ox-LDL
(0 to 50 mg/ml) for four hours. After incuba-
tion, cells were washed with PBS, and RNA
was isolated, electrophoresed, and transferred
onto nylon membranes, as described in the
Methods section. Northern blots were hybrid-
ized with 32P-labeled murine cDNA probe for
ICAM-1 and then rehybridized with GAPDH
probe. Autoradiographs were developed by
exposing blots to x-ray films. Quantitative
analysis was performed by densitometric scan-
ning of blots and was normalized with GAPDH
message. Northern blot is a representative of
three separate experiments.
Fig. 2. Effect of LDL and ox-LDL on monocyte adhesion to endothelial cells. (A) Endothelial cells were incubated with either LDL or ox-LDL
(0 to 50 mg/ml) for 24 hours before the addition of radiolabeled monocytes (*P 5 0.01; **P 5 0.004; #P 5 0.001). (B) Lipoprotein-activated
endothelial cells were preincubated with saturating concentrations of anti–ICAM-1 (10 mg/ml) for two hours before the addition of radiolabeled
monocytes (*P 5 0.05). Monocyte adhesion assay was performed using 51Cr-labeled monocytes as described in the Methods section. Data presented
as monocyte adhesion (cpm/plate) are the mean 6 se of three experiments. The addition of anti–ICAM-1 to control or LDL-treated cells had no
effect on monocyte adhesion (data not shown).
of monocytes to ECs (Fig. 2B). However, the addition induction of monocyte adhesion. Incubation of ECs with
PMA, an activator of PKC, for four hours significantlyof saturating concentrations of anti–ICAM-1 had no sig-
nificant effect on monocyte adhesion in control or increased monocyte adhesion when compared with con-
trols (Fig. 3A), and the increased adhesion could beLDL-treated cells (data not shown). Additional studies
indicated that Lysopc also significantly induced the mono- blocked by preincubation with saturating concentrations
of anti–ICAM-1 antibody (70% when compared withcyte adhesion to ECs. Monocyte adhesion in control and
Lysopc-treated ECs as cpm/plate were as follows: PMA-treated cells, data not shown). The depletion of
cellular PKC by prolonged incubation with PMA signifi-control 5 1328 6 215, 25 mm Lysopc 5 2305 6 360, and
50 mm Lysopc 5 2514 6 556. cantly decreased the monocyte adhesion when compared
with PMA-treated cells (Fig. 3A). Further stimulation of
Role of PKC, PTK, and Gi-proteins in PKC-depleted cells with PMA did not induce monocyte
ox-LDL–induced monocyte adhesion adhesion (Fig. 3A), confirming the effective depletion
of PKC in these cells. Treatment of PKC-depleted cellsIn these studies, we examined the involvement of vari-
ous intracellular signaling pathways in ox-LDL–mediated with ox-LDL did not alter the ox-LDL–mediated induc-
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Fig. 3. Role of protein kinase C (PKC) in basal and ox-LDL–induced monocyte adhesion. (A) Endothelial cells were either stimulated with PMA
(50 nm) for 4 hours or with ox-LDL (50 mg/ml) for 24 hours (*P 5 0.05). In another set of experiments, cellular PKC was depleted by incubating
endothelial cells with PMA for 24 hours. PKC-depleted cells were stimulated either with PMA for 4 hours or ox-LDL for 24 hours. After stimulation,
radiolabeled monocytes were added to individual wells, and an adhesion assay was performed as described in Figure 1 and the Methods section.
(B) Endothelial cells were pretreated with calphostin C (100 nm) for 1 hour prior to the stimulation with either PMA (50 nm) for 4 hours or with
ox-LDL (50 mg/ml) for 24 hours (*P 5 0.01). Calphostin was present throughout the incubation period. Monocyte adhesion assay was performed
as described in the Methods section. data are the means of three experiments.
tion of monocyte adhesion (Fig. 3A). In additional stud-
ies, pretreatment of ECs with calphostin C, a PKC inhibi-
tor, did not inhibit ox-LDL–induced monocyte adhesion,
whereas pretreatment of ECs with calphostin C signifi-
cantly inhibited PMA-induced monocyte adhesion (Fig.
3B). Similarly, preincubation of ECs with pertussis toxin,
an agent that blocks Gi-protein–mediated effects, did not
show a significant decrease in monocyte adhesion to ECs
(monocyte adhesion, cpm 3 1000: control 5 3996 6 572;
ox-LDL, 50 mg/ml 5 9233 6 815; ox-LDL 1 pertussis
toxin 5 8503 6 453, P 5 NS). These data suggested that
ox-LDL–induced monocyte adhesion to ECs was not
dependent on pathways involving PKC or Gi-protein–
mediated pathways.
Fig. 4. Involvement of protein tyrosine kinase (PTK) in ox-LDL–Using specific tyrosine kinase inhibitors, additional ex-
induced endothelial cell-monocyte adhesion. Endothelial cells were pre-
periments were performed to assess the involvement of incubated with either herbimycin (10 mm) or genistein (25 mg/ml) for
1 hour prior to the stimulation of cells with ox-LDL (50 mg/ml) fortyrosine kinase-mediated pathways in ox-LDL–induced
24 hours. After incubation, radiolabeled monocytes were added tomonocyte adhesion to ECs. Preincubation of ECs with endothelial cell monolayer, and an adhesion assay was performed as
herbimycin (5 mm) and genistein (12.5 mg/ml), which described in the Methods section. Inhibitors were present throughout
the incubation period. Data are the means of three experiments (*P 5are specific PTK inhibitors, significantly decreased the
0.006; **P 5 0.04; #P 5 0.003).adhesion of monocytes to ECs both in control (data not
shown) and in ox-LDL (50 mg/ml for 24 hr)-treated ECs
(Fig. 4). Additional studies indicated that both herbi-
mycin (10 mm) and genistein (25 mg/ml) significantly in- Role of PKC, PTK and Gi-protein in ox-LDL–induced
ICAM-1 mRNA expressionhibited monocyte adhesion measured after four hours
of ox-LDL incubation with ECs (data not shown). The Because ox-LDL–induced monocyte adhesion was as-
incubation of these inhibitors for 4 or 24 hours did not sociated with increased ICAM-1 message, additional
cause cytotoxicity or alter viability of cells as compared studies were performed to identify the cellular signal
with control cells, as assessed by trypan blue exclusion transduction pathways associated with ox-LDL–induced
EC ICAM-1 gene expression. Incubation of ECs withand measuring the number of cells.
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Table 1. Quantitative analysis of the effect of depletion of cellular (Fig. 5). Because no detectable or very faint ICAM-1
protein kinase C [by treatment with phorbol 12-myristate 13-
message was observed in herbimycin-treated cells, noacetate (PMA), 24 hr] and calphostin on oxidized-low density
lipoprotein (ox-LDL)-induced intercellular adhesion molecule-1 accurate densitometric scanning data were obtained to
(ICAM-1) mRNA expression quantitate the inhibition of the ICAM-1 signal. Further-
more, pretreatment of ECs with herbimycin and gen-Treatment with
No prior Treatment with PMA calphostin istein inhibited ox-LDL–induced ICAM-1 protein ex-
Agonist treatment 50 nm, 24 hr 100 nm, 1 hr pression (densitometric values include control 5 0.09,
None 0.18 0.21 0.15 ox-LDL 5 0.43, ox-LDL plus herbimycin 5 0.29, ox-LDL
PMA 50 nm 0.58 0.20 0.10
plus genistein 5 0.14; data are the average of two experi-Ox-LDL 50 lg /ml 0.34 0.35 0.32
ments done in duplicates).Endothelial cells were incubated with either PMA (50 nm) or ox-LDL (50
mg/ml) for 4 hours. In additional experiments, cells were first depleted of PKC Additional studies were performed to examine the pos-
(by incubation with PMA, 50 nm, for 24 hr) and then stimulated with either ox- sible involvement of cAMP-mediated signaling eventsLDL (50 mg/ml) or PMA (50 nm) for 4 hours. In another set, cells were preincu-
bated in the presence or absence of calphostin C (100 nm) for 1 hour prior to in monocyte adhesion to glomerular ECs and ICAM-1
the stimulation of cells with either PMA (50 nm) or ox-LDL (50 mg/ml) for 4 mRNA expression. The results indicated that the prein-hours. After the incubation, cells were washed, RNA isolated and used for
Northern blot analysis for ICAM-1 as described in Figure 1 and in the Methods cubation of ECs for four hours with either forskolin
section. Quantitative analysis of ICAM-1 message was performed by densitomet- (50 mm) or pertussis toxin (50 ng/ml), agents that increaseric scanning of Northern blots and normalization with GAPDH message. Results
are expressed as arbitrary quantitative units, and the data are an average of two intracellular cAMP levels, did not significantly stimulate
experiments done in duplicates. monocyte adhesion to glomerular ECs and ICAM-1 ex-
pression (data not shown). Preincubation of cells with
H-89 (25 mm), an inhibitor of cAMP-dependent protein
kinase A, did not affect ox-LDL–mediated effects (dataPMA, an activator of PKC, stimulated ICAM-1 mRNA
not shown), suggesting cAMP-independent pathwaysexpression by approximately threefold when compared
exist in these cells.with control (Table 1). The depletion of PKC activity
with prolonged treatment of ECs with PMA consistently Effect of LDL and ox-LDL on PTK activity
decreased ICAM-1 gene expression when compared
Because PTK was involved in ox-LDL–induced mono-with PMA stimulation (Table 1). Further activation of
cyte adhesion and EC ICAM-1 expression, additionalPKC-depleted ECs with PMA for four hours did not
studies were performed to examine the effect of LDL
induce EC ICAM-1 mRNA expression as compared with
and ox-LDL on EC PTK activity using an in vitro kinase
PKC-depleted cells (Table 1). The incubation of ox-LDL
assay. The activation of EC membranes (for 15 and 30
with PKC-depleted ECs did not inhibit ICAM-1 mRNA
min) with ox-LDL (10 mg/ml), but not with LDL (10 mg/
transcripts when compared with ox-LDL–treated control
ml), stimulated PTK activity by approximately 30 to 38%
cells (Table 1). Similarly, preincubation of ECs with cal- when compared with controls. PTK activity (cpm/mg
phostin C, a PKC inhibitor, did not significantly inhibit membrane protein, average of 3 assays) at 15 minutes
ox-LDL–induced EC ICAM-1 gene expression (Table of activation was: control, 2317 6 185; LDL (10 mg/ml),
1), suggesting that ox-LDL–induced ICAM-1 gene ex- 2420 6 181; and ox-LDL (10 mg/ml), 3208 6 110 (control
pression is not mediated through PKC pathways. Addi- vs. ox-LDL, P 5 0.01). Similarly, the PTK activity at 30
tional studies were performed to examine the effect of minutes after activation was: control, 2640 6 59; LDL
calphostin C on PMA-induced EC ICAM-1 message and (10 mg/ml), 2630 6 137; and ox-LDL (10 mg/ml), 3451 6
showed a significant decrease in ICAM-1 mRNA expres- 123 (control vs. ox-LDL, P 5 0.004).
sion (Table 1), verifying the effectiveness of calphostin
C as a tool to determine PKC-mediated effects.
DISCUSSIONStudies were performed to examine the role of G pro-
teins in ox-LDL–induced EC ICAM-1 gene expression We have shown that the stimulation of glomerular
by pretreating ECs with pertussis toxin, an agent that ECs with ox-LDL but not native LDL induced mRNA
covalently modifies and inactivates Gi proteins. The pre- message and cellular surface expression of ICAM-1, a
incubation of ECs with pertussis toxin did not alter the principal adhesion molecule involved in monocyte adhe-
EC ICAM-1 message as compared with control cells sion. Furthermore, ox-LDL–induced monocyte adhesion
treated with ox-LDL (arbitrary densitometric values for was blocked by neutralizing antibodies for ICAM-1, sug-
pertussis toxin plus ox-LDL and ox-LDL–treated cells 5 gesting a primary role for ICAM-1 in atherogenic lipo-
0.36 and 0.37, respectively). The involvement of PTK in protein-mediated monocyte adhesion. Although these
EC ICAM-1 mRNA message was examined by preincu- studies indicated the primary role of ICAM-1 in ox-
bating ECs with herbimycin, a specific PTK inhibitor. LDL–mediated monocyte-EC interactions, other adhe-
Preincubation of ECs with herbimycin nearly completely sion molecules [that is, vascular cell adhesion molecule-
1 (VCAM-1)] may also play a role in these events. Inblocked ox-LDL–induced ICAM-1 gene expression
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Fig. 5. Involvement of PTK in ox-LDL–induced endo-
thelial cell ICAM mRNA expression. Endothelial cells
were preincubated with herbimycin (10 mm) for one hour
prior to the stimulation of cells with ox-LDL (50 mg/ml)
for four hours. After incubation, cells were washed, and
RNA was isolated and used for Northern blot analysis
for ICAM-1, as described in the Methods section. The
Northern blot is representative of three separate experi-
ments.
preliminary studies (R. Pai, V.S. Kamanna, unpublished late ICAM-1 and monocyte adhesion may be dependent
on differential bioactive molecules generated duringobservations), we have observed that neutralizing anti-
bodies for VCAM-1 also inhibited (20 to 30%) monocyte mm-LDL or ox-LDL preparations. In this regard, Kume,
Cybulsky, and Gimbrone have shown that the Lysopc,adhesion to ECs. Thus, we propose that the interaction of
intrinsic glomerular cells with atherogenic lipoproteins a major component of ox-LDL, induced leukocyte adhe-
sion molecules in human and rabbit aortic ECs [35].stimulates the surface expression of glomerular capillary
endothelial adhesion molecules facilitating the firm ad- Similarly, we have also shown that Lysopc significantly
increased monocyte adhesion to glomerular ECs andhesion of monocytes. The pathobiological ability of ath-
erogenic lipoproteins to induce mesangial cell monocyte EC ICAM-1 mRNA expression. Because ECs had no
appreciable scavenger receptor activity, and as heparinchemoattractant peptides (for example, MCP-1 and
M-CSF) further creates a conducive environment for (an agent that blocks binding to native LDL receptor)
had no effect on ox-LDL–mediated monocyte adhesion,cell to cell interactions between monocytes and intrinsic
glomerular cells leading to the transendothelial migra- the stimulatory effect of ox-LDL on endothelial–mono-
cyte adhesion may not be through the interaction withtion of monocytes and growth within the mesangium
[5, 6]. scavenger receptors or native LDL receptors. Based on
observations of this and previous studies, it appears thatIn preliminary studies, we observed that minimally ox-
LDL (mm-LDL, prepared by FeSO4-mediated oxidation Lysopc and/or other yet unidentified components of
ox-LDL may have primary roles in ox-LDL–mediatedat 48C) had a marginal insignificant effect on ICAM-1
mRNA expression and monocyte adhesion (data not responses.
Although LDL is a primary lipoprotein transportingshown). However, only a marginal increase in conju-
gated-diene formation was observed in our mm-LDL cholesterol to various peripheral tissues, the atherogenic
properties have been primarily proposed to its oxida-preparations (approximately 10 to 15% increase over
native LDL) when compared with much higher degree tively modified variants and its components to transform
monocytes into lipid-laden foam-like cells and to activateof conjugated dienes in mm-LDL preparations reported
in previous studies [32, 33]. Such variability of mm-LDL cells to synthesize multiple cytoregulatory peptides in-
volved in glomerular and vascular injury [35–37]. The inpreparations and the cellular responses have been re-
ported earlier [32]. This difference in degree of conju- vivo occurrence of oxidatively modified LDL variants in
human renal tissue is not clearly established. However,gated-dienes in mm-LDL preparations (that may be de-
pendent on source of LDL samples) may have contributed the in vitro ability of glomerular cells to modify LDL
oxidatively may provide clues to the possibility of in vivoto the inability to stimulate monocyte adhesion to glo-
merular ECs. Previous studies have shown that the treat- LDL modification [38]. Recent studies have shown the
presence of ox-LDL–like modified LDL within rat glo-ment of aortic ECs with mm-LDL induced monocyte
binding, and this process has been shown to be mediated meruli with focal glomerulosclerosis induced by both
puromycin amininucleoside and high dietary cholesterolby endothelial GRO family of chemokines, but not
through ICAM-1 or other adhesion molecule-mediated [39]. Increased circulating concentrations of lipid peroxi-
dation products associated with decreased levels of en-events [34]. The differential effect of mm-LDL in aortic
ECs [20, 34] and ox-LDL in glomerular ECs to stimu- dogenous antioxidative factors were also observed in
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patients with chronic renal failure [40, 41], thus providing LDL–mediated stimulation of ICAM-1 mRNA message
and monocyte adhesion, suggesting pertussis toxin-sensi-a favorable environment for oxidation-related events. In
support of these observations, recent studies in humans tive Gi-protein–independent signaling events in ox-LDL–
mediated effects in glomerular ECs.demonstrated the localization of ox-LDL within the glo-
meruli of diverse renal diseases [42]. However, the pre- We have previously shown that the activation of glo-
merular cells with oxidatively modified variants of LDLcise concentrations of ox-LDL within the glomerular
tissue are not known. Ox-LDL is a very heterogeneous and Lysopc-stimulated glomerular cell membrane tyro-
sine kinase activity and tyrosine phosphorylation ofmolecule, and the identification and characterization of
all the potential components of ox-LDL for various cellu- transmembrane proteins (40 to 200 kDa) [26]. In addi-
tion, atherogenic lipoproteins stimulated mesangial celllar responses are not well established.
Although the major signal transduction events associ- mitogen-activated protein kinase, a downstream signal-
ing event that is generally associated with activation ofated with lipoproteins have been attributed to the stimu-
lation of PKC and increased generation of cAMP [19, tyrosine kinase-mediated cascade [25]. Considering these
observations, we examined whether ox-LDL–induced cel-20], intracellular signaling processes by atherogenic lipo-
proteins associated with pathobiological cellular re- lular responses are dependent on activation of tyrosine
kinase pathway. Activation of ECs with ox-LDL stimu-sponses within the glomerular cells are not known. Fur-
thermore, the involvement of lipoprotein-induced signal lated PTK activity, as measured by using in vitro tyrosine
kinase assay. Preincubation of ECs with genistein andtransduction events that regulate monocyte adhesion to
ECs is not clearly understood. In this study, we examined herbimycin, specific inhibitors of PTK, significantly de-
creased monocyte adhesion to ECs. Similarly, ox-LDL–the role of PKC, Gi-protein, and PTK in ox-LDL–medi-
ated induction of EC ICAM-1 expression and monocyte induced ICAM-1 expression was blocked by pretreat-
ment of cells with PTK inhibitor. These data suggest theadhesion. Using both PKC activation and depletion ap-
proaches, we have shown the regulatory role of PKC in involvement of tyrosine kinase-mediated effects of ox-
LDL to stimulate endothelial adhesive properties. Inglomerular EC ICAM-1 expression and monocyte adhe-
sion. However, similar PKC-depletion studies indicated support of these observations, previous studies have
shown the dependency of PTK-mediated pathways inthat the ox-LDL–induced monocyte adhesion and
ICAM-1 expression was not dependent on PKC. Because TNF-a–induced adhesion molecule expression in vascu-
lar endothelial and glomerular mesangial cells [27, 28].cellular PKC depletion by prolonged incubation with
PMA may not deplete all species of PKC, additional Because agents that induce cAMP levels are shown to
stimulate aortic EC MCP-1 and M-CSF expression andexperiments were done using calphostin C, a specific
inhibitor of PKC. The results from these studies indi- monocyte adhesion, cAMP-dependent signaling pro-
cesses may also play an important role in glomerularcated that the pretreatment of cells with calphostin C
had no effect on ox-LDL–induced monocyte adhesion ECs [20]. In our studies, forskolin or pertussis toxin,
agents that increase intracellular cAMP levels, did notand ICAM-1 transcript expression, whereas pretreat-
ment of cells with this inhibitor blocked PMA-induced stimulate monocyte adhesion to glomerular ECs and
ICAM-1 expression (data not shown). Preincubation ofeffects. Thus, it is unlikely that the ox-LDL–mediated
stimulation of ICAM-1 gene expression and associ- cells with H-89, an inhibitor of cAMP-dependent protein
kinase A, did not affect ox-LDL–mediated effects (dataated monocyte adhesion is regulated through PKC-medi-
ated pathways. not shown), suggesting cAMP-independent pathways in
these cells.Previous studies have shown that the impaired endothe-
lial-dependent vasodilation (in response to receptor-medi- Several possible mechanisms could account for the
observed effects of ox-LDL to modulate EC adhesiveated agonists, acetylcholine, and serotonin) associated
with hypercholesterolemia-mediated vascular disease is, properties. One possibility is that any changes in the
physical dynamics of the membrane caused by choles-at least in part, regulated by guanine nucleotide-binding
proteins (Gi) [21, 22]. Ox-LDL and lysophosphatidyl- terol, phospholipids, or oxidative products could poten-
tially modulate transmembrane signaling events. Addi-choline, a proposed active component of ox-LDL, was
also shown to alter Gi-protein levels and to inhibit endo- tionally, apo B-100 has Src-homology (SH1) domains
that are kinase-activating regions for PTK and thus maythelial-dependent relaxation via pertussis toxin-sensitive
Gi-protein–dependent pathway [23, 24]. Using pertussis induce tyrosine kinase activity and downstream signaling
events [43]. However, we have noted that the activationtoxin (an agent that covalently modifies certain G sub-
units, such as Gai, preventing their ability to interact of glomerular ECs with ox-LDL, but not LDL-stimu-
lated tyrosine kinase activity, suggesting the role of oxi-with certain receptors coupled to cognate G proteins),
we examined the involvement of pertussis toxin-sensitive dative products in tyrosine kinase-mediated signaling
events. Previous studies have indicated the involvementGi protein in ox-LDL–mediated endothelial effects. Pre-
treatment of ECs with pertussis toxin did not alter the ox- of PTK-mediated pathways in nuclear factor kB (NF-kB)
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